Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake

被引:270
作者
Checkoway, H
Powers, K
Smith-Weller, T
Franklin, GM
Longstreth, WT
Swanson, PD
机构
[1] Univ Washington, Sch Publ Hlth & Community Med, Dept Environm Hlth, Seattle, WA 98195 USA
[2] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA
关键词
caffeine; coffee; neuroprotective agents; Parkinson disease; smoking; tea;
D O I
10.1093/aje/155.8.732
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A reduced risk for Parkinson's disease (PD) among cigarette smokers has been observed consistently during the past 30 years. Recent evidence suggests that caffeine may also be protective. Findings are presented regarding associations of PD with smoking, caffeine intake, and alcohol consumption from a case-control study conducted in western Washington State in 1992-2000. Incident PD cases (n = 210) and controls (n = 347), frequency matched on gender and age were identified from enrollees of the Group Health Cooperative health maintenance organization. Exposure data were obtained by in-person questionnaires. Ever having smoked cigarettes was associated with a reduced risk of PD (odds ratio (OR) = 0.5, 95% confidence interval (CI): 0.4, 0.8). A stronger relation was found among current smokers (OR = 0.3, 95% CI: 0.1, 0.7) than among ex-smokers (OR = 0.6, 95% CI: 0.4, 0.9), and there was an inverse gradient with pack-years smoked (trend p < 0.001). No associations were detected for coffee consumption or total caffeine intake or for alcohol consumption. However, reduced risks were observed for consumption of 2 cups/day or more of tea (OR = 0.4, 95% CI: 0.2, 0.9) and two or more cola drinks/day (OR = 0.6, 95% CI: 0.3, 1.4). The associations for tea and cola drinks were not confounded by smoking or coffee consumption.
引用
收藏
页码:732 / 738
页数:7
相关论文
共 37 条
  • [1] PARKINSONS-DISEASE - PATHOPHYSIOLOGY
    AGID, Y
    [J]. LANCET, 1991, 337 (8753) : 1321 - 1324
  • [2] Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
    Ascherio, A
    Zhang, SMM
    Hernán, MA
    Kawachi, I
    Colditz, GA
    Speizer, FE
    Willett, WC
    [J]. ANNALS OF NEUROLOGY, 2001, 50 (01) : 56 - 63
  • [3] NICOTINE ENHANCES 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE NEUROTOXICITY
    BEHMAND, RA
    HARIK, SI
    [J]. JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) : 776 - 779
  • [4] Smoking, alcohol, and coffee consumption preceding Parkinson's disease - A case-control study
    Benedetti, MD
    Bower, JH
    Maraganore, DM
    McDonnell, SK
    Peterson, BJ
    Ahlskog, JE
    Schaid, DJ
    Rocca, WA
    [J]. NEUROLOGY, 2000, 55 (09) : 1350 - 1358
  • [5] ENVIRONMENTAL ANTECEDENTS OF YOUNG-ONSET PARKINSONS-DISEASE
    BUTTERFIELD, PG
    VALANIS, BG
    SPENCER, PS
    LINDEMAN, CA
    NUTT, JG
    [J]. NEUROLOGY, 1993, 43 (06) : 1150 - 1158
  • [6] Oxygen radical absorbance capacity of the phenolic compounds in plant extracts fractionated by high-performance liquid chromatography
    Caldwell, CR
    [J]. ANALYTICAL BIOCHEMISTRY, 2001, 293 (02) : 232 - 238
  • [7] Neuroprotection in the MPTP parkinsonian C57BL/6 mouse model by a compound isolated from tobacco
    Castagnoli, KP
    Steyn, SJ
    Petzer, JP
    Van der Schyf, CJ
    Castagnoli, N
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (05) : 523 - 527
  • [8] Genetic and environmental risk factors for Parkinson's disease in a Chinese population
    Chan, DKY
    Woo, J
    Ho, SC
    Pang, CP
    Law, LK
    Ng, PW
    Hung, WT
    Kwok, T
    Hui, E
    Orr, K
    Leung, MF
    Kay, R
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (05) : 781 - 784
  • [9] Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease
    Chen, JF
    Xu, K
    Petzer, JP
    Staal, R
    Xu, YH
    Beilstein, M
    Sonsalla, PK
    Castagnoli, K
    Castagnoli, N
    Schwarzschild, MA
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (10) : art. no. - RC143
  • [10] METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE
    CHIBA, K
    TREVOR, A
    CASTAGNOLI, N
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) : 574 - 578